| 000 | 00850nam a2200229 a 4500 | ||
|---|---|---|---|
| 008 | 190131s2002^^^^ne^a^^^^^^^^^^001^0^eng^d | ||
| 020 | _a9780444538567 | ||
| 035 | _aMX001002028490 | ||
| 040 |
_aUNAMX _bspa _erda _cUNAMX _dUNAMX |
||
| 050 | 4 |
_aRA1238 _bG74 2012 |
|
| 100 | 1 |
_aGreaves, P. _q(Peter), _eautor |
|
| 245 | 1 | 0 |
_aHistopathology of preclinical toxicity studies : _binterpretation and relevance in drug safety studies / _cPeter Greaves |
| 250 | _aFourth edition | ||
| 264 | 1 |
_aAmsterdam : _bElsevier/AP, _c2012 |
|
| 300 |
_avi, 886 páginas : _bilustraciones (algunas a color) |
||
| 336 |
_atexto _2rdacontent |
||
| 337 |
_asin medio _2rdamedia |
||
| 338 |
_avolumen _2rdacarrier |
||
| 650 | 4 |
_aMedicamentos _xToxicología |
|
| 650 | 4 |
_aMedicamentos _xPruebas de toxicidad |
|
| 650 | 4 |
_aAnimales de laboratorio _xHistopatología |
|
| 999 |
_c14928 _d14928 |
||